Answers are grounded in this paper and cite their sources.
Simplification of the structure but maintenance of the biological activity—this (successful) strategy was the basis for the synthesis of 1, the “non-glycosamino” glycan analogue of the pentasaccharide domain of heparin responsible for binding antithrombin III. The disaccharide corresponding to the EF building block could be prepared from a protected derivative of fragment GH by basecatalyzed epimerization at C5. The number of synthetic steps was thus significantly reduced.
No takes yet. Share an insight, caveat, or question.
Lucas et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: